169 related articles for article (PubMed ID: 10770789)
21. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
Khorvash F; Mostafavizadeh K; Mobasherizadeh S
Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
[TBL] [Abstract][Full Text] [Related]
22. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
23. Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.
Werth BJ; Vidaillac C; Murray KP; Newton KL; Sakoulas G; Nonejuie P; Pogliano J; Rybak MJ
Antimicrob Agents Chemother; 2013 May; 57(5):2376-9. PubMed ID: 23422917
[TBL] [Abstract][Full Text] [Related]
24. Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.
Patel JA; Pachucki CT; Lentino JR
Antimicrob Agents Chemother; 1993 Feb; 37(2):339-41. PubMed ID: 8452367
[TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibilities of four species of coagulase-negative staphylococci.
Fass RJ; Helsel VL; Barnishan J; Ayers LW
Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
[TBL] [Abstract][Full Text] [Related]
26. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Ho JL; Klempner MS
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
[TBL] [Abstract][Full Text] [Related]
27. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Voss A; Machka K; Lenz W; Milatovic D
Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
29. Identification of mecA-related oxacillin resistance in staphylococci by the E test and the broth microdilution method.
Petersson AC; Miorner H; Kamme C
J Antimicrob Chemother; 1996 Mar; 37(3):445-56. PubMed ID: 9182101
[TBL] [Abstract][Full Text] [Related]
30. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.
Goh S; Loeffler A; Lloyd DH; Nair SP; Good L
BMC Microbiol; 2015 Nov; 15():262. PubMed ID: 26560174
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Stuart JI; John MA; Milburn S; Diagre D; Wilson B; Hussain Z
Int J Antimicrob Agents; 2011 Mar; 37(3):248-52. PubMed ID: 21295951
[TBL] [Abstract][Full Text] [Related]
32. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Van der Auwera P; Van Laethem Y; Klastersky J
J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
[TBL] [Abstract][Full Text] [Related]
34. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Nodzo SR; Boyle KK; Frisch NB
J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
[TBL] [Abstract][Full Text] [Related]
35. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
[TBL] [Abstract][Full Text] [Related]
36. Methicillin-resistant staphylococci isolated from animals.
van Duijkeren E; Box AT; Heck ME; Wannet WJ; Fluit AC
Vet Microbiol; 2004 Oct; 103(1-2):91-7. PubMed ID: 15381271
[TBL] [Abstract][Full Text] [Related]
37. Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects.
Martins A; Cunha Mde L
Microbiol Immunol; 2007; 51(9):787-95. PubMed ID: 17895595
[TBL] [Abstract][Full Text] [Related]
38. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
39. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
[TBL] [Abstract][Full Text] [Related]
40. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
Bakar NS; Zin NM; Basri DF
Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
